The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.
K. C. Kent Lloyd is a professor in the Department of Surgery, School of Medicine, director of the Mouse Biology Program and NAMs Testing Center and associate director of the Comprehensive Cancer ...